WAMU 88.5 - American University Radio | The Mind Is Our Medium
Now Playing

Nestle To Buy Pfizer's Infant-Nutrition Line

Swiss food and drink giant Nestle announced a deal Monday to acquire Pfizer Inc.'s infant-nutrition business for $11.85 billion in a bid to boost sales in emerging markets. Before the announcement, Nestle already had the largest share of the global baby-formula market at just under 20 percent.